Enhancing HER2 Evaluation: Correlation between APIS Breast Cancer Subtyping Kit and IHC/ISH for Accurate HER2 Quantification

被引:0
|
作者
Gasior, Anna
Gorniak, Joanna
Rollinson, Sara
Gough, Leanne
Wegscheider, Anne-Sophie
Niendorf, Axel
机构
关键词
D O I
10.1158/1538-7445.SABCS23-PO3-01-05
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PO3-01-05
引用
收藏
页数:2
相关论文
共 50 条
  • [41] Novel Quantitative HER2 Assay for Determining Dynamic HER2 Expression in the HER2 IHC 0 "Ultra-Low" Setting: Implications for Precision Therapy in HER2-Breast Cancer
    Petricoin, Emanuel F.
    Corgiat, Brian A.
    O'Shaughnessy, Joyce
    LoRusso, Patricia
    Weinberg, Kris
    Davis, Justin
    Gawryletz, Chelsea
    CANCER RESEARCH, 2023, 83 (05)
  • [42] Effect of the 2013 ASCO-CAP HER2 Testing Guideline on the Management of IHC/HER2 2+Invasive Breast Cancer
    Yamada, Mai
    Kubo, Makoto
    Yamamoto, Hidetaka
    Yamashita, Nami
    Kai, Masaya
    Zaguirre, Karen
    Kaneshiro, Kazuhisa
    Shimazaki, Akiko
    Hayashi, Saori
    Kawaji, Hitomi
    Mori, Masaki
    Oda, Yoshinao
    Nakamura, Masafumi
    ANTICANCER RESEARCH, 2021, 41 (08) : 4143 - 4149
  • [43] Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer
    Dupouy, D.
    Ciftlik, A. T.
    Fiche, M.
    Heintze, D.
    Bisig, B.
    de Leval, L.
    Gijs, M. A. M.
    VIRCHOWS ARCHIV, 2016, 469 : S21 - S21
  • [44] Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer
    Dupouy, Diego G.
    Ciftlik, Ata Tuna
    Fiche, Maryse
    Heintze, Deborah
    Bisig, Bettina
    de Leval, Laurence
    Gijs, Martin A. M.
    SCIENTIFIC REPORTS, 2016, 6
  • [45] Continuous quantification of HER2 expression by microfluidic precision immunofluorescence estimates HER2 gene amplification in breast cancer
    Diego G. Dupouy
    Ata Tuna Ciftlik
    Maryse Fiche
    Déborah Heintze
    Bettina Bisig
    Laurence de Leval
    Martin A. M. Gijs
    Scientific Reports, 6
  • [46] Correlation between HER2 amplification level and response to neoadjuvant treatment with trastuzumab and chemotherapy in HER2 positive breast cancer.
    Antolin, Silvia
    Garcia-Caballero, Lucia
    Reboredo, Cristina
    Molina Diaz, Aurea
    Mosquera, Joaquin
    Vazquez-Boquete, Angel
    Gallego, Rosalia
    Paz Santiago, Maria
    Concha, Angel
    Eva Perez, Maria
    Calvo, Lourdes
    Garcia-Caballero, Tomas
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [47] Impact of HER2 Copy Number in IHC HER2 2+/FISH Positive Breast Cancer on Outcome of Adjuvant Trastuzumab Treatment
    Borley, A.
    Mercer, T.
    Morgan, M.
    Barrett-Lee, P.
    Jasani, B.
    JOURNAL OF PATHOLOGY, 2013, 231 : 19 - 19
  • [48] Activating HER2 Mutations in HER2 Gene Amplification Negative Breast Cancer
    Bose, Ron
    Kavuri, Shyam M.
    Searleman, Adam C.
    Shen, Wei
    Shen, Dong
    Koboldt, Daniel C.
    Monsey, John
    Goel, Nicholas
    Aronson, Adam B.
    Li, Shunqiang
    Ma, Cynthia X.
    Ding, Li
    Mardis, Elaine R.
    Ellis, Matthew J.
    CANCER DISCOVERY, 2013, 3 (02) : 224 - 237
  • [49] HER2 Signaling in Breast Cancer
    Shin, Incheol
    TRANSLATIONAL RESEARCH IN BREAST CANCER, 2021, 1187 : 53 - 79
  • [50] HER2 assessment in breast cancer
    Sapino, Anna
    EUROPEAN JOURNAL OF CANCER, 2014, 50 : S30 - S31